Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Preferred Shares (2018 - 2026)

Trafalgar International (GCAN) posted Preferred Shares of $9112.0 for Q1 2026, down 99.95% on a QoQ basis from $19.0 million in Q4 2025, and little changed year-over-year from $9112.0 in Q1 2025.

Analysis

Trafalgar International (GCAN) Preferred Shares (2018 - 2026) Analysis & Trends

Trafalgar International has reported Preferred Shares for 9 years, with the latest figure at $9112.0 in Q1 2026.

  • On a quarterly basis, Preferred Shares changed 0.0% year-over-year to $9112.0 in Q1 2026; TTM through Mar 2026 was $9112.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $19.0 million, up 208416.24% from the prior year.
  • Preferred Shares was $9112.0 for Q1 2026 at Trafalgar International, down from $19.0 million in the prior quarter.
  • The five-year high for Preferred Shares was $19.0 million in Q4 2025, with the low at $9112.0 in Q1 2022.
  • Average Preferred Shares over 5 years is $1.1 million, with a median of $9112.0 recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: Preferred Shares dropped 3.19% in 2022, then jumped 208416.24% in 2025.
  • Over 5 years, Preferred Shares stood at $9112.0 in 2022, then changed by 0.0% to $9112.0 in 2023, then changed by 0.0% to $9112.0 in 2024, then surged by 208416.24% to $19.0 million in 2025, then tumbled by 99.95% to $9112.0 in 2026.
  • The last three Preferred Shares figures came in at $9112.0 (Q1 2026), $19.0 million (Q4 2025), and $9112.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn -
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
10 Trafalgar International 217,335.05 217,335.05 - 9,112.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 9,112.00
Dec 31, 2025 19.00 Mn
Sep 30, 2025 9,112.00
Jun 30, 2025 9,112.00
Mar 31, 2025 9,112.00
Dec 31, 2024 9,112.00
Sep 30, 2024 9,112.00
Jun 30, 2024 9,112.00
Mar 31, 2024 9,112.00
Dec 31, 2023 9,112.00
Sep 30, 2023 9,112.00
Jun 30, 2023 9,112.00
Mar 31, 2023 9,112.00
Dec 31, 2022 9,112.00
Sep 30, 2022 9,112.00
Jun 30, 2022 9,112.00
Mar 31, 2022 9,112.00
Dec 31, 2021 9,112.00
Sep 30, 2021 9,112.00
Jun 30, 2021 9,412.00